As of Mar 19
| +0.17 / +3.05%|
The 2 analysts offering 12-month price forecasts for Rockwell Medical Inc have a median target of 6.50, with a high estimate of 11.00 and a low estimate of 2.00. The median estimate represents a +13.04% increase from the last price of 5.75.
The current consensus among 2 polled investment analysts is to Buy stock in Rockwell Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.